Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy
- 22 March 2004
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 86 (1) , 4-9
- https://doi.org/10.1002/jso.20039
Abstract
Background A dramatic response to chemotherapy in some patients with multiple bilateral and initially unresectable liver metastases (LM) from colorectal cancer sometimes leads to their disappearance from imaging studies. Our study was aimed at assessing the evolution of these metastases when they were also not found during liver surgery. Patients Among 104 hepatectomized patients for colorectal LM in 4 years, 15 patients were retrospectively eligible. Eligibility criteria were: initially unresectable LM; a dramatic response to chemotherapy; and the complete disappearance of at least one LM on imaging studies (ultrasonography (US), computed tomography, and magnetic resonance) during more than 3 months. In four patients (27%), the disappeared LM could be found and treated at laparotomy. The main selection criterion for the 11 studied patients of this series was the impossibility of finding and treating the disappeared LM sited in the remaining liver after hepatectomy, resulting in “missing LM.” Results After a median follow‐up of 31 months (range: 18–55) for the series, eight patients among the eleven (73%) did not present any recurrence of the missing LM. The median follow‐up was 31.3 months for these eight patients. The three recurrences occurred respectively at 5, 5, and 8 months after surgery. Conclusions The disappearance of LM after chemotherapy on high‐quality imaging studies and after intra‐operative liver exploration resulted in their definitive cure in approximately 70% of cases. The current dogma stipulating an obligatory resection of the initially affected part of the liver is no longer acceptable. J. Surg. Oncol. 2004;86:4–9.Keywords
This publication has 9 references indexed in Scilit:
- Improvement in Perioperative Outcome After Hepatic ResectionAnnals of Surgery, 2002
- Genetic and Histological Assessment of Surgical Margins in Resected Liver Metastases From Colorectal CarcinomaArchives of Surgery, 2002
- Radiofrequency ablation of hepatic metastasesSeminars in Oncology, 2002
- Liver Metastases From Colorectal Cancer: The Turning PointJournal of Clinical Oncology, 2002
- Role for Surgical Cytoreduction in Multimodality Treatments for CancerAnnals of Surgical Oncology, 2001
- Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialPublished by Elsevier ,2000
- Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal CancerAnnals of Surgery, 1999
- Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastasesJournal of Surgical Oncology, 1998
- How I Do It: Intraoperative use of radiofrequency treatment allows an increase in the rate of curative liver resectionJournal of Surgical Oncology, 1998